Utama › Limfoma Sel-B › Illinois › Chicago
Kajian klinikal Limfoma Sel-B di Chicago, IL
12 kajian untuk Limfoma Sel-B sedang mencari peserta di lokasi dalam dan sekitar Chicago (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Mengambil pesertaFasa 3
- Rush University Medical Center, Chicago
- University of Chicago Medical Center, Chicago
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Mengambil pesertaFasa 1
- The University of Chicago Medical Center (UCMC), Chicago
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Mengambil pesertaFasa 2
- Research Site, Chicago
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
Mengambil pesertaFasa 1
- University of Chicago Comprehensive Cancer Center, Chicago
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Mengambil pesertaFasa 1/2
- University of Chicago Medical Center, Chicago
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Mengambil pesertaFasa 1
- The David and Etta Jonas Center for Cellular Therapy, Chicago
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Mengambil pesertaFasa 3
- Northwestern, Chicago
- University of Chicago, Chicago
DALY II USA/ MB-CART2019.1 for DLBCL
Mengambil pesertaFasa 2
- Robert H Lurie Cancer Center, Chicago
Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma
Mengambil pesertaFasa 2
- Northwestern University, Chicago
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Mengambil pesertaFasa 1/2
- University of Illinois at Chicago Cancer Center, Chicago
Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma
Mengambil pesertaFasa 1/2
- The University of Chicago Medical Center (UCMC), Chicago
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Mengambil pesertaFasa 1
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Kajian Limfoma Sel-B di bandar lain
- New York City, NY19 kajian
- Houston, TX16 kajian
- Nashville, TN11 kajian
- Philadelphia, PA11 kajian
- Rochester, MN10 kajian
- Baldwin Park, CA9 kajian
- Milwaukee, WI9 kajian
- Cleveland, OH9 kajian
- Salt Lake City, UT8 kajian
- Boston, MA8 kajian
- Columbus, OH7 kajian
- Pittsburgh, PA7 kajian
Kajian lain di Chicago
- Kanser Paru-paru Bukan Sel Kecil61 kajian
- Kanser Payudara58 kajian
- Kanser (semua jenis)51 kajian
- Kanser Metastatik45 kajian
- Kanser Prostat45 kajian
- Obesiti41 kajian
- Kanser Paru-paru41 kajian
- Kanser Ovari36 kajian
- Strok34 kajian
- Kanser Kolorektal33 kajian
- Kegagalan Jantung31 kajian
- Berat Badan Berlebihan28 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.